E072 – Translational research in dermatological diseases

Objectives

The Group’s main objectives focus on strengthening the research lines described below, establishing regional (groups from the Galician Health Research Institutes), national, and international collaborations, promoting independent research studies, participating in Phase I clinical trials sponsored by the pharmaceutical industry, and launching four new areas of work:

• Sexually transmitted infections.
• Qualitative research in dermatology.
• Nursing care for dermatological diseases.
• Health education in dermatology.

Through multidisciplinary collaboration with the e-ducasaúde Teaching Innovation Group (service-learning, innovation with ICTs) at the University of Santiago de Compostela (USC) and with the Faculty of Nursing and Podiatry at the University of A Coruña (UDC), the aim is to carry out educational innovation projects in the field of dermatology.

Lines of research

• Inflammatory dermatological diseases.
• Pediatric dermatology and genodermatoses.
• Surgery in dermatological conditions.
• Quality of life and healthy habits in patients with dermatological diseases.

Análisis Molecular y Celular en Dermatitis Atópica (MAP-AD): Identificación de Biomarcadores y Dianas Terapéuticas con Enfoque en Inflamación y Fibrosis
Código del proyecto: PI25/00440
Entidad financiadora: Instituto de Salud Carlos III.
Duración: 3 años
Cuantía: 170.000 €
Investigador/a principal: Ángeles Flórez Menéndez

• Moreiras-Arias N, Nieto-Fontarigo JJ, Salgado FJ, González-Vilas D, Paredes-Suárez C, Combo-García E, Rodríguez-Otero C, Flórez Á. Novel Therapeutic Strategies for Atopic Dermatitis: Biomarker Modulation and Clinical Implications. A Systematic Review. PMID: 41609895. Clin Rev Allergy Immunol. 2026;69(1):4. doi: 10.1007/s12016-025-09129-z.
• Chao Maseda B, Paredes Suárez MC, Cánovas Seva C, Flórez Á. Exantema escarlatiniforme por Arcanobacterium: reporte de un caso y revisión de la literatura [Arcanobacterium haemolyticum-associated scarlatiniform exanthem: a case report and literature review]. PMID: 41512586. Semergen. 2026;52(1):102655. doi: 10.1016/j.semerg.2025.102655.
• Cánovas Seva C, Martínez Leboráns L, Batalla A, Sánchez-Aguilar Y Rojas MD, Flórez Á. Lentigo Maligna: Contemporary Surgical Management and Outcome: A Review. PMID: 41537210. Ann Ital Chir. 2026;97(1):36-62. doi: 10.62713/aic.4228.
• Seva CC, Paredes-Suárez C, Batalla A, Flórez Á. Patch Testing Confirms Clindamycin-Induced Acute Generalised Exanthematous Pustulosis: A Case Report. PMID: 40926559. Contact Dermatitis. 2026;94(1):83-85. doi: 10.1111/cod.70029.
• Grau-Pérez M, Mercader-García P, Giménez-Arnau AM, Sanz-Sánchez T, Ninet VZ, Guijarro SC, Miquel FJM, Salvador JFS, González-Pérez R, González IR, Baldrich ES, Carrascosa JM, de Frutos FJO, Serna MR, Ortega MEG, Suárez CP, Triviño FJN, Chicharro P, Andreu M, Gilo AS, Pereyra Rodríguez JJ, Nieto MAP, Melé-Ninot G, Guillén PS, de la Fuente EG, Elosua-González M, Munera-Campos M, Romero FT, Descalzo MÁ, Borrego L. Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024. PMID: 41365615. Contact Dermatitis. 2025. doi: 10.1111/cod.70048.
• Buján Bonino C, Cánovas Seva C, Suárez Peñaranda JM, Flórez Á. Autonomic denervation dermatitis: reviewing additional triggers besides total knee arthroplasty. PMID: 40751400. Clin Exp Dermatol. 2025;50(12):2506-2507. doi: 10.1093/ced/llaf360.
• Mrowietz U, Meyer C, Großschädl K, Weger W, Wolf P, Gooderham M, O’Toole A, Vender R, Gerdes S, Körber A, Bellinato F, Gisondi P, Bardazzi F, Sacchelli L, Zengarini C, Dauden E, Llamas-Velasco M, Santamaría C, Abalde T, Flórez Á, Salgado-Boquete L, Baskan EB, Solak SS, Hartmann A. Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study. PMID: 40232616. Am J Clin Dermatol. 2025;26(5):819-827.  doi: 10.1007/s40257-025-00944-w.
• Munera-Campos M, González Quesada A, Espasandín Arias M, Lasheras-Pérez MA, de la Cueva Dobao P, Montero-Vilchez T, Ruiz-Villaverde R, Chicharro P, Gilaberte Y, Elosua-González M, Curto Barredo L, Pereyra-Rodríguez JJ, Silvestre Salvador JF, Batalla A, Arias-Santiago S, Navarro Triviño FJ, Navarro Bielsa A, Roustan Gullón G, Bertolín-Colilla M, Betlloch-Mas I, Castaño I, Couselo-Rodríguez C, Rodríguez-Serna M, Sanabria-de la Torre R, Ruiz Carrascosa JC, Sánchez J, Rosell Díaz Á, Giménez Arnau AM, Martínez-Fernández S, García-Doval I, Descalzo-Gallego MÁ, Carrascosa Carrillo JM. Characteristics, Treatment, and Safety Profile of Patients With Atopic Dermatitis According to Eligibility for Randomized Clinical Trials: An Analysis From the Spanish Atopic Dermatitis Registry (BIOBADATOP). PMID: 41344609. Actas Dermosifiliogr. 2025;117(1):104489. doi: 10.1016/j.ad.2025.104489.